ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Educational Symposium

Hemodiafiltration in 2026: Rationale, Evidence, and the Path to Implementation

October 23, 2026 | 12:45 PM - 01:45 PM

Location: TBD Room, Hyatt Regency Denver

Session Description

Hemodiafiltration (HDF) has evolved from a promising technological advance into a therapy supported by an expanding mechanistic rationale, randomized controlled clinical trials, and large registry analyses. Several international studies suggest that, compared with high-flux hemodialysis, high-volume HDF has demonstrated potential survival and cardiovascular benefits. However, important evidence gaps remain, and adoption in the United States has been limited by operational, regulatory, and economic considerations. This symposium provides a balanced, evidence-based review of HDF, covering mechanistic rationale, trial and registry data, and remaining uncertainties. Practical considerations for implementation are also addressed, including infrastructure requirements, patient selection, workflow integration, and systems-level barriers.

Seating is limited and available on a first-come, first-served basis to fully paid Annual Meeting participants. Doors open approximately 15 minutes prior to each symposium. When a room reaches capacity, ASN will shut down access to the room. No other participants will be allowed to enter the room, regardless of the number of participants who exit the room during the activity.

Support is provided by an educational grant from Fresenius Medical Care.

Learning Objective(s)

  • Explain the physiologic rationale and mechanistic basis for enhanced clearance of middle molecules with HDF
  • Critically appraise randomized controlled clinical trial and registry data comparing high-volume HDF with high-flux hemodialysis
  • Describe practical and systems-based considerations for implementing HDF in contemporary dialysis practice

Learning Pathway(s)

  • Dialysis
  • Kidney Biology and Physiology

Moderator

Presentations